These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19520192)

  • 1. Comparative proteomic analysis of colon cancer cells in response to oxaliplatin treatment.
    Yao Y; Jia XY; Tian HY; Jiang YX; Xu GJ; Qian QJ; Zhao FK
    Biochim Biophys Acta; 2009 Oct; 1794(10):1433-40. PubMed ID: 19520192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin.
    Liu W; Wang G; Cao X; Luo X; Li Z; Deng Y; Li X; Wang S; Liu M; Hu J; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):280-286. PubMed ID: 22528234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment.
    Zhao J; Wen G; Ding M; Pan JY; Yu ML; Zhao F; Weng XL; Du JL
    Protein Pept Lett; 2012 Dec; 19(12):1272-80. PubMed ID: 22670670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines.
    Lee SY; Kim GT; Roh SH; Song JS; Kim HJ; Hong SS; Kwon SW; Park JH
    Biosci Biotechnol Biochem; 2009 Apr; 73(4):811-6. PubMed ID: 19352032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic analysis of cell cycle-dependent apoptosis induced by transforming growth factor-beta.
    Tian HY; Zhang KH; Gao X; Lei WW; Zhang L; Yu ML; Song JG; Zhao FK
    Biochim Biophys Acta; 2009 Oct; 1794(10):1387-97. PubMed ID: 19450710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA.
    Wang X; Fu Z; Zhao Y; Wu X; Shen W
    Eur J Cancer Prev; 2011 May; 20(3):190-8. PubMed ID: 21200325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.
    Zhang XL; Hu AB; Cui SZ; Wei HB
    World J Gastroenterol; 2012 Feb; 18(7):646-53. PubMed ID: 22363135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
    Fillet M; Cren-Olivé C; Renert AF; Piette J; Vandermoere F; Rolando Ch; Merville MP
    J Proteome Res; 2005; 4(3):870-80. PubMed ID: 15952734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
    Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
    Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
    Li X; Ran L; Fang W; Wang D
    Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
    Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
    Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
    Shiragami R; Murata S; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Koda K
    Int J Oncol; 2013 Aug; 43(2):431-8. PubMed ID: 23754252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.